Chesterfield, MO, United States of America

Arthur Glenn Romero

This inventor holds 38 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Pharmacia & Upjohn Company, The Upjohn Co., Magenta Therapeutics, Inc.. Active years: 1994-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arthur Glenn Romero. Retrieved from https://idiyas.com/inventor/arthur-glenn-romero

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 6)

% Patents Active = 57.9

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 151(Granted Patents)

Location History:

Kalamazoo, MI (US) (1994 - 2008)
Chesterfield, MO (US) (2007 - 2024)

Company Filing History:

18 out of 523

Pharmacia & Upjohn Company

Magenta Therapeutics, Inc.

patents

4. 3 out of 1,381

Washington University

Elan Pharmaceuticals, Inc.

patents

8. 1 out of 11

Imago Biosciences, Inc.

11. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2024

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

CNS Activity

Anti-Viral Agents

Aryl Hydrocarbon Receptor

Tricyclic Compounds

Heterocyclic Amines

Dopamine Receptors

2-Aminoindans

Quinolines

Tetrahydroquinolines

Epidermis Treatment

Antibacterial Agents

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12006337 - Mitogen-activated protein kinase inhibitors, methods of making, and methods of use thereof (2024-06-11),

2. 11661409 - Acid addition salts, compositions, and methods of treating (2023-05-30),

3. 11479541 - Acid addition salts, compositions, and methods of treating thereof (2022-10-25),

4. 11407771 - Mitogen-activated protein kinase inhibitors, methods of making, and methods of use thereof (2022-08-09),

5. 11390590 - Methods and processes for the preparation of KDM1A inhibitors (2022-07-19),

6. 10919900 - Aryl hydrocarbon receptor antagonists and uses thereof (2021-02-16),

7. 10457683 - Aryl hydrocarbon receptor antagonists and uses thereof (2019-10-29),

8. 10351572 - Aryl hydrocarbon receptor antagonists and uses thereof (2019-07-16),

9. 9707244 - Compositions and methods for treating conditions that affect epidermis (2017-07-18),

10. 9512111 - N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease (2016-12-06),

11. 9434753 - Modified creatine compounds (2016-09-06),

12. 9187470 - Anti-mucus drugs and uses therefor (2015-11-17),

13. 8420646 - Tricyclic tetrahydroquinoline antibacterial agents (2013-04-16),

14. 7605157 - Tricyclic tetrahydroquinoline antibacterial agents (2009-10-20),

15. 7388118 - Amine 1,2- and 1,3-diol compounds (2008-06-17),

As a specialist in inventions and inventors, I can assist you with that. Let's craft an engaging article about inventor Arthur Glenn Romero from Chesterfield, MO (US).

Title: The Inventive Journey of Arthur Glenn Romero

Introduction:

Arthur Glenn Romero, a prolific inventor based in Chesterfield, MO, has made significant contributions to the field of pharmaceuticals with his innovative patents.

Latest Patents:

Romero's latest patents include groundbreaking inventions such as acid addition salts, compositions, and methods of treating neuroinflammation-related diseases. An example is the tartrate salt of 3-(1H-indol-5-yl)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridine, which showcases his expertise in developing novel pharmaceutical compositions.

Career Highlights:

Having secured an impressive 37 patents, Romero has showcased his dedication to advancing the healthcare industry. Throughout his career, he has worked with reputable companies like Pharmacia & Upjohn Company and The Upjohn Co., demonstrating his commitment to innovation in collaboration with industry leaders.

Collaborations:

Romero has collaborated with talented individuals in the field, including coworkers such as Chiu-Hong Lin and Susanne R Haadsma-Svensson. These collaborations have further enriched his inventive journey and led to the development of groundbreaking solutions for complex healthcare challenges.

Conclusion:

In conclusion, Arthur Glenn Romero stands out as a visionary inventor whose work has significantly impacted the pharmaceutical landscape. His dedication to innovation and collaboration underscores his commitment to advancing healthcare solutions for the betterment of society.

Profile summary based on public USPTO records.